I. C. Haznedaroglu, "Current concerns of undertreatment and overtreatment in chronic myeloid leukemia based on European LeukemiaNet 2013 recommendations," EXPERT OPINION ON PHARMACOTHERAPY , vol.14, no.15, pp.2005-2010, 2013
Haznedaroglu, I. C. 2013. Current concerns of undertreatment and overtreatment in chronic myeloid leukemia based on European LeukemiaNet 2013 recommendations. EXPERT OPINION ON PHARMACOTHERAPY , vol.14, no.15 , 2005-2010.
Haznedaroglu, I. C., (2013). Current concerns of undertreatment and overtreatment in chronic myeloid leukemia based on European LeukemiaNet 2013 recommendations. EXPERT OPINION ON PHARMACOTHERAPY , vol.14, no.15, 2005-2010.
Haznedaroglu, Ibrahim. "Current concerns of undertreatment and overtreatment in chronic myeloid leukemia based on European LeukemiaNet 2013 recommendations," EXPERT OPINION ON PHARMACOTHERAPY , vol.14, no.15, 2005-2010, 2013
Haznedaroglu, Ibrahim C. . "Current concerns of undertreatment and overtreatment in chronic myeloid leukemia based on European LeukemiaNet 2013 recommendations." EXPERT OPINION ON PHARMACOTHERAPY , vol.14, no.15, pp.2005-2010, 2013
Haznedaroglu, I. C. (2013) . "Current concerns of undertreatment and overtreatment in chronic myeloid leukemia based on European LeukemiaNet 2013 recommendations." EXPERT OPINION ON PHARMACOTHERAPY , vol.14, no.15, pp.2005-2010.
@article{article, author={Ibrahim C. Haznedaroglu}, title={Current concerns of undertreatment and overtreatment in chronic myeloid leukemia based on European LeukemiaNet 2013 recommendations}, journal={EXPERT OPINION ON PHARMACOTHERAPY}, year=2013, pages={2005-2010} }